Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025
CURRENT ASSETS
Cash and cash equivalents	$ 4,539,940	$ 4,631,666
Investments	3,723,657	3,688,909
Accounts receivable	10,000	0
Prepaid expenses	684,972	734,951
Total current assets	8,958,569	9,055,526
TOTAL ASSETS	8,958,569	9,055,526
CURRENT LIABILITIES
Accounts payable	179,188	187,006
Deferred liability	84,615	130,769
Accrued expenses	185,082	10,506
Total current liabilities	448,885	328,281
TOTAL LIABILITIES	448,885	328,281
Additional paid-in capital	20,150,876	20,145,210
Common stock - $0.03 par value; authorized 3,333,334; 1,010,514 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	30,316	30,316
Accumulated deficit	(11,671,508)	(11,448,281)
TOTAL STOCKHOLDERS’ EQUITY	8,509,684	8,727,245
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 8,958,569	$ 9,055,526